For citations:

Gulyayev A.Ye., Zhaugasheva S.K., Kim T.V., Piven L.I. PHARMACOECONOMIC FEASIBILITY OF USING THE DRUG «XYLTOPHY®» (INSULIN DEGLUDEC U100 + LIRAGLUTIDE 3,6 MG) FOR THE TREATMENT OF THE SECOND TYPE DIABETES MELIUS IN CONVENTIONAL CLINICAL PRACTICE. Medicine and ecology. 2020;(3):88-95. (In Russ.)